Contact: Ellen Goldbaum
University at Buffalo
Caption: Talal led the study, which is the first to track in real-time, how the drug telaprevir inhibits viral replication in the liver.
Credit: Douglas Levere, University at Buffalo
Usage Restrictions: None
Related news release: How long should HCV treatment last? Study suggests answers are complex